A detailed history of Nuveen Asset Management, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 150,373 shares of PRME stock, worth $787,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150,373
Previous 108,093 39.11%
Holding current value
$787,954
Previous $957,000 9.93%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$6.35 - $9.39 $268,478 - $397,009
42,280 Added 39.11%
150,373 $1.05 Million
Q4 2023

Feb 14, 2024

BUY
$5.59 - $9.55 $6,545 - $11,183
1,171 Added 1.1%
108,093 $957,000
Q3 2023

Nov 14, 2023

SELL
$9.5 - $15.07 $154,593 - $245,234
-16,273 Reduced 13.21%
106,922 $1.02 Million
Q2 2023

Aug 14, 2023

BUY
$11.41 - $17.05 $1.24 Million - $1.86 Million
109,067 Added 771.99%
123,195 $1.8 Million
Q4 2022

Feb 14, 2023

BUY
$16.24 - $21.12 $229,438 - $298,383
14,128 New
14,128 $262,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $502M
More about PRME
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.